What’s going on?
- The drug could be rolled out to pharmacies within the country over the next week or so, according to Reuters.
- Coronavir and Avifavir are two prescription drugs for COVID-19 that are based off of Favipiravir, which was made in Japan to treat viruses, according to Reuters.
Don’t forget ...
Coronavir received approval after a small clinical trial with 168 patients, Reuters reporters.
Russia continues to seek vaccine success
- The trials “did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” the study’s authors wrote.
- “Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection.”